Lantus dosage
Reading Document
Medical Text Search
Lantus insulin glargine dosage dosing regimen
GradeResponse
The retrieval gave limited information. Here is a comprehensive answer on Lantus dosing from clinical knowledge:
Lantus (Insulin Glargine U-100) Dosing
Lantus is a long-acting basal insulin analog given once daily (occasionally twice daily in some patients) by subcutaneous injection.
Starting Doses
| Patient Population | Initial Dose |
|---|---|
| Type 2 Diabetes (insulin-naive) | 0.1–0.2 units/kg/day SC once daily |
| Type 2 Diabetes (alternative) | Fixed start of 10 units/day SC once daily |
| Type 1 Diabetes | 0.2–0.4 units/kg/day SC once daily (basal portion of total daily dose, typically ~40–50% of TDD) |
| Switching from NPH insulin (once daily) | Same unit-for-unit dose |
| Switching from NPH insulin (twice daily) | Reduce by ~20%; titrate up as needed |
| Switching from another basal insulin analog | Same unit-for-unit dose generally |
Titration
The most common outpatient titration protocol ("treat-to-target"):
- Increase by 2 units every 3 days if fasting blood glucose (FBG) consistently >130 mg/dL (7.2 mmol/L)
- More aggressive titration: increase by 1 unit/day until FBG target is met
- Target FBG: 80–130 mg/dL (ADA) or as individualized
Administration
- Route: Subcutaneous only (abdomen, thigh, upper arm, or buttock)
- Timing: Same time each day; commonly at bedtime or in the morning — consistency matters more than specific time
- Do NOT mix with other insulins or diluents
- Do NOT administer IV
- Rotate injection sites within the same region
Dose Range
- Typical maintenance: 10–100+ units/day depending on insulin resistance
- No strict upper limit; dose is titrated to glycemic target
Special Populations
| Population | Consideration |
|---|---|
| Renal impairment | Insulin requirements may decrease; monitor closely and reduce dose as needed |
| Hepatic impairment | Gluconeogenesis reduced; insulin requirements may decrease |
| Elderly | Start lower (e.g., 0.1 units/kg/day); higher hypoglycemia risk |
| Pregnancy | Not FDA-approved; insulin NPH or detemir traditionally preferred; some use off-label |
| Pediatric (≥6 years, T1D) | Approved; dosing same as adults on weight basis |
Hypoglycemia Management
- If FBG <80 mg/dL on 2 consecutive days, reduce dose by 10–20% or by 2–4 units
- If severe hypoglycemia occurs, review timing, dose, carbohydrate intake, and renal function
Key Notes
- Lantus U-100 has a duration of ~20–24 hours; it is relatively peakless
- Lantus U-300 (Toujeo) is a more concentrated formulation with a longer, flatter profile — the two are not interchangeable unit-for-unit
- Biosimilars include Basaglar (glargine U-100) — interchangeable in most settings
Clinical note: Insulin dosing must always be individualized based on glucose monitoring, A1c, diet, activity level, and comorbidities. The doses above are starting points, not fixed targets.
Lantus 14 u will reduce grbs by
Medical Text Search
insulin glargine units blood glucose reduction effect 1 unit insulin glucose lowering
GradeResponse
There is no fixed, predictable answer to this — and clinically it matters to understand why.
How Much Will Lantus 14 Units Lower Blood Glucose?
It depends on the individual's insulin sensitivity, quantified by the Insulin Sensitivity Factor (ISF) or Correction Factor.
The "1800 Rule" (for rapid-acting insulin)
For basal insulin like Lantus, the relevant concept is different. Lantus does not work as a correction dose — it lowers fasting/basal glucose over 24 hours by suppressing hepatic glucose output, not by a predictable mg/dL drop per unit.
Estimating ISF (if used for dose reasoning)
ISF = 1800 ÷ Total Daily Dose (TDD)
| TDD | ISF (approx. mg/dL per unit) |
|---|---|
| 20 units/day | ~90 mg/dL per unit |
| 30 units/day | ~60 mg/dL per unit |
| 50 units/day | ~36 mg/dL per unit |
| 70 units/day | ~26 mg/dL per unit |
So if a patient's TDD is 14 units (Lantus only, no bolus):
ISF ≈ 1800 ÷ 14 ≈ ~129 mg/dL per unit 14 units × 129 ≈ ~1800 mg/dL total — this is not a single-dose correction; it reflects 24-hour basal coverage.
Practically Speaking
- Lantus 14 units SC daily does not cause a sudden or calculable blood glucose drop in the way a rapid-acting insulin would
- Its effect is gradual over 20–24 hours — it reduces fasting blood glucose by suppressing overnight hepatic glucose production
- Expected fasting BG reduction from basal insulin initiation (per clinical trials like ORIGIN and treat-to-target studies): typically 30–60 mg/dL reduction in fasting glucose when titrated appropriately in T2D patients
Bottom Line
| Question | Answer |
|---|---|
| Will 14 u Lantus cause a sharp glucose drop? | No — it acts slowly over 24 hours |
| How much does it lower fasting BG? | Typically 30–60 mg/dL in fasting glucose over days of consistent dosing |
| Is 14 units a standard starting dose? | Yes — the standard starting dose for insulin-naive T2D is 10–14 units/day, titrated upward |
| Can you predict exact mg/dL reduction? | No — varies by weight, insulin resistance, diet, renal function, and concurrent medications |
If you need to estimate a correction dose (rapid-acting insulin), the ISF formula above applies. Lantus itself is not used for acute corrections.
This is a shared conversation. Sign in to Orris to start your own chat.